| #82 |
Rafael Gustavo Hermes |
Dsm Ip Assets B.V. |
1 |
| #82 |
Fernando Cisneros |
Dsm Ip Assets B.V. |
1 |
| #82 |
Isaac BITTAR |
Dsm Ip Assets B.V. |
1 |
| #82 |
Dominique Grimler |
Novartis Ag |
1 |
| #82 |
Manuel Steiner |
List Ag |
1 |
| #82 |
John Geurts |
Dsm Ip Assets B.V. |
1 |
| #82 |
Hendrik Moorlag |
Hoffmann-La Roche |
1 |
| #82 |
Samuel Hintermann |
Novartis Ag |
1 |
| #82 |
Torgny Fjeldskaar |
Cannondale Bicycle |
1 |
| #82 |
Hansjoerg Lehmann |
Novartis Ag |
1 |
| #82 |
Maurice Courtois |
— |
1 |
| #82 |
Lucie Lovelle |
Johnson & Johnson |
1 |
| #82 |
Michael Gressly |
Dsm Ip Assets B.V. |
1 |
| #82 |
Daniel Heizler |
Basf Se |
1 |
| #82 |
Lukas Emanuel Rickenbacher |
Alstom Technology |
1 |
| #82 |
Felix Aschmann |
Depuy Synthes Products |
1 |
| #82 |
Juraj Sibik |
Cambridge Enterprise Limited |
1 |
| #82 |
Christina Lorenz |
Curevac Ag |
1 |
| #82 |
Eileen Jackson |
Dsm Ip Assets B.V. |
1 |
| #82 |
Thomas Zoller |
Novartis Ag |
1 |
| #82 |
Dominik Rudmann |
Flisom Ag |
1 |
| #82 |
Nicola Tufilli |
Novartis Ag |
1 |
| #82 |
Oliver SANDER |
Novartis Ag |
1 |
| #82 |
Stephan ACKERMANN |
Dsm Ip Assets B.V. |
1 |
| #82 |
Colin Morton |
Ciba Specialty Chemicals |
1 |
| #82 |
Jörn Stitz |
4-Antibody Ag |
1 |
| #82 |
Pamela LAGALI |
Friedrich Miescher Institute For Biomedical Research |
1 |
| #82 |
Francois Jean-Charles Natt |
Novartis Ag |
1 |
| #82 |
Gregory Lebrat |
— |
1 |
| #82 |
Philippe Dennler |
Comet Ag |
1 |
| #82 |
Xu Xu |
Dsm Ip Assets B.V. |
1 |
| #82 |
Juergen REINHARDT |
Novartis Ag |
1 |
| #82 |
Grahame Woollam |
Theravance Biopharma R&D Ip |
1 |
| #82 |
Andreas Ritzen |
H. Lundbeck A/S |
1 |
| #82 |
Nicole Pezous |
Novartis Ag |
1 |
| #82 |
Therese Cronin |
University of Pennsylvania |
1 |
| #82 |
Stephanie J.M. Krammer-Lukas |
Dsm Ip Assets B.V. |
1 |
| #82 |
Carl Becker |
Ciba-Geigy |
1 |
| #82 |
Svenja Gschwind |
Dsm Ip Assets B.V. |
1 |
| #82 |
Dominique Pfister |
Adobe |
1 |
| #82 |
Mathias Frederiksen |
Novartis Ag |
1 |
| #82 |
Rahel Heule |
Universitatsspital Basel |
1 |
| #82 |
Peter Gedeck |
Novartis Ag |
1 |
| #82 |
Aurelie Brelin |
Novozymes A/S |
1 |
| #82 |
Moise Azria |
Novartis Ag |
1 |
| #82 |
Björn Keiner |
Novartis Ag |
1 |
| #82 |
Christiane Schweiggert |
Dsm Ip Assets B.V. |
1 |
| #82 |
Giancarlo Francese |
Novartis Ag |
1 |
| #82 |
Jean-Claude Bianchi |
Novartis Ag |
1 |
| #82 |
Reto Mettler |
Straumann Holding Ag |
1 |